|
1
|
Pillay-van Wyk V, Msemburi W, Laubscher R,
Dorrington RE, Groenewald P, Glass T, Nojilana B, Joubert JD,
Matzopoulos R, Prinsloo M, et al: Mortality trends and
differentials in South Africa from 1997 to 2012: Second national
burden of disease study. Lancet Glob Health. 4:e642–e653.
2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Statistics South Africa: Mid-year
population estimates. Statistics South Africa, Pretoria, pp1-50,
2022.
|
|
3
|
Coetzee L, Bogler L, De-Neve JW,
Bärnighausen T, Geldsetzer P and Vollme S: HIV, antiretroviral
therapy and non-communicable diseases in sub-Saharan Africa:
Empirical evidence from 44 countries over the period 2000 to 2016.
J Int AIDS Soc. 22(e25364)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Statistics South Africa: Mortality and
causes of death in South Africa: Findings from death notification.
Statistics South Africa, Pretoria, pp1-145, 2017.
|
|
5
|
Mohan J, Ghazi T and Chuturgoon AA: A
critical review of the biochemical mechanisms and epigenetic
modifications in HIV- and antiretroviral-induced metabolic
syndrome. Int J Mol Sci. 22(12020)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Masuku SKS, Tsoka-Gwegweni J and Sartorius
B: HIV and antiretroviral therapy-induced metabolic syndrome in
people living with HIV and its implications for care: A critical
review. J Diabetol. 10:41–47. 2019.
|
|
7
|
Levitt NS, Peer N, Steyn K, Lombard C,
Maartens G, Lambert EV and Dave JA: Increased risk of dysglycaemia
in South Africans with HIV; especially those on protease
inhibitors. Diabetes Res Clin Pract. 119:41–47. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Murakami M and Kudo I: Phospholipase A2. J
Biochem. 131:285–292. 2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Dennis EA, Cao J, Hsu YH, Magrioti V and
Kokotos G: Phospholipase A2 enzymes: Physical structure, biological
function, disease implication, chemical inhibition, and therapeutic
intervention. Chem Rev. 111:6130–6185. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Khan SA and Ilies MA: The phospholipase A2
superfamily: Structure, isozymes, catalysis, physiologic and
pathologic roles. Int J Mol Sci. 24(1353)2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Massaad C, Paradon M, Jacques C, Salvat C,
Bereziat G, Berenbaum F and Olivier JL: Induction of secreted type
IIA phospholipase A2 gene transcription by interleukin-1beta. Role
of C/EBP factors. J Biol Chem. 275:22686–22694. 2000.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lee C, Park DW, Lee J, Lee TI, Kim YJ, Lee
YS and Baek SH: Secretory phospholipase A2 induces apoptosis
through TNF-alpha and cytochrome c-mediated caspase cascade in
murine macrophage RAW 264.7 cells. Eur J Pharmacol. 536:47–53.
2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Iyer A, Lim J, Poudyal H, Reid RC, Suen
JY, Webster J, Prins JB, Whitehead JP, Fairlie DP and Brown L: An
inhibitor of phospholipase A2 group IIA modulates adipocyte
signaling and protects against diet-induced metabolic syndrome in
rats. Diabetes. 61:2320–2329. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kuefner MS, Pham K, Redd JR, Stephenson
EJ, Harvey I, Deng X, Bridges D, Boilard E, Elam MB and Park EA:
Secretory phospholipase A2 group IIA modulates insulin
sensitivity and metabo. J Lipid Res. 58:1822–1833. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kuefner MS, Deng X, Stephenson EJ, Pham K
and Park EA: Secretory phospholipase A2 group IIA
enhances the metabolic rate and increases glucose utilization in
response to thyroid hormone. FASEB J. 33:738–749. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sato H, Taketomi Y, Ushida A, Isogai Y,
Kojima T, Hirabayashi T, Miki Y, Yamamoto K, Nishito Y, Kobayashi
T, et al: The adipocyte-inducible secreted phospholipases PLA2G5
and PLA2G2E play distinct roles in obesity. Cell Metab. 20:119–132.
2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Guijas C, Rodríguez JP, Rubio JM, Balboa
MA and Balsinde J: Phospholipase A2 regulation of lipid droplet
formation. Biochim Biophys Acta. 1841:1661–1671. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Peña L, Meana C, Astudillo AM, Lordén G,
Valdearcos M, Sato H, Murakami M, Balsinde J and Balboa MA:
Critical role for cytosolic group IVA phospholipase A2 in early
adipocyte differentiation and obesity. Biochim Biophys Acta.
1861:1083–1095. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Khan MI and Hariprasad G: Human secretary
phospholipase A2 mutations and their clinical implications. J
Inflamm Res. 13:551–561. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Breitling LP, Koenig W, Fischer M, Mallat
Z, Hengstenberg C, Rothenbacher D and Brenner H: Type II secretory
phospholipase A2 and prognosis in patients with stable coronary
heart disease: Mendelian randomization study. PLoS One.
6(e22318)2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
World health Organization: Noncommunicable
Disease Surveillance, Monitoring and Reporting: STEPwise approach
to NCD risk factor surveillance (STEPS). https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/steps.
Accessed January 13, 2014.
|
|
22
|
Ngwa NE, Peer N, Matsha TE, de-Villiers A,
Sobngwi E and Kengne AP: Associations of leucocyte telomere length
with cardio-metabolic risk profile in a South African HIV-infected
population. Medicine (Baltimore). 101(5e28642)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
National Kidney Foundation. K/DOQI
clinical practice guidelines for chronic kidney disease:
Evaluation, classification, and stratification. Am J Kidney Dis. 39
(2 Suppl 1):S1–S266. 2002.PubMed/NCBI
|
|
24
|
Allain CC, Poon LS, Chan CS, Richmond W
and Fu PC: Enzymatic determination of total serum cholesterol. Clin
Chem. 20:470–475. 1974.PubMed/NCBI
|
|
25
|
Jabbar J, Siddique I and Qaiser R:
Comparison of two methods (precipitation manual and fully automated
enzymatic) for the analysis of HDL and LDL cholesterol. J Pak Med
Assoc. 56:59–61. 2006.PubMed/NCBI
|
|
26
|
Mcgowan MW, Artiss JD, Strandbergh DR and
Zak BA: Peroxidase-coupled method for the colorimetric
determination of serum triglycerides. Clin Chem. 29:538–542.
1983.PubMed/NCBI
|
|
27
|
Friedewald WT, Levy RI and Fredrickson DS:
Estimation of the concentration of low-density lipoprotein
cholesterol in plasma, without use of the preparative
ultracentrifuge. Clin Chem. 18:499–502. 1972.PubMed/NCBI
|
|
28
|
Miller SA, Dykes DD and Polesky HF: A
simple salting out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res. 16(1215)1988.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Holmes MV, Simon T, Exeter HJ, Folkersen
L, Asselbergs FW, Guardiola M, Cooper JA, Palmen J, Hubacek JA,
Carruthers KF, et al: Secretory phospholipase A2-IIA and
cardiovascular disease: A Mendelian randomization study. J Am Coll
Cardiol. 62:1966–1976. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Akinkuolie AO, Lawler PR, Chu AY,
Caulfield M, Mu J, Ding B, Nyberg F, Glynn RJ, Ridker PM,
Hurt-Camejo E, et al: Group IIA secretory phospholipase
A2, vascular inflammation, and incident cardiovascular
disease. Arterioscler Thromb Vasc Biol. 39:1182–1190.
2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
No authors listed. Obesity: preventing and
managing the global epidemic. Report of a WHO consultation. World
Health Organ Tech Rep Ser. 894:i–xii, 1-253. 2000.PubMed/NCBI
|
|
32
|
World Health Organization (WHO). Waist
Circumference and Waist-Hip Ratio: Report of a WHO Expert
Consultation, Geneva, 8-11 December 2008. WHO, Geneva, 2011.
|
|
33
|
Williams B, Mancia G, Spiering W, Rosei
EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak
A, et al: 2018 ESC/ESH guidelines for the management of arterial
hypertension. Eur Heart J. 39:3021–3104. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Diagnosis management and prevention of the
common dyslipidaemias in South Africa-clinical guideline, 2000.
South African medical association and lipid and atherosclerosis
society of Southern Africa working group. S Afr Med J. 90:164–174,
176-178. 2000.PubMed/NCBI
|
|
35
|
World Health Organization (WHO):
Definition, diagnosis and classification of diabetes mellitus and
its complications. Report of a WHO Consultation. WHO, Geneva,
1999.
|
|
36
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Alberti KGMM, Eckel RH, Grundy SM, Zimmet
PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith
SC Jr, et al: Harmonizing the metabolic syndrome: A joint interim
statement of the international diabetes federation task force on
epidemiology and prevention; national heart, lung, and blood
institute; American heart association; world heart federation;
international atherosclerosis society; and international
association for the study of obesity. Circulation. 120:1640–1645.
2009.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Statistics South Africa: Mid-year
population estimates. Statistics South Africa, Pretoria, pp1-20,
2015.
|
|
39
|
Xu L, Zhou J, Huang S, Huang Y, Le Y,
Jiang D, Wang F, Yang X, Xu W, Huang X, et al: An association study
between genetic polymorphisms related to lipoprotein-associated
phospholipase A(2) and coronary heart disease. Exp Ther Med.
5:742–750. 2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wootton PT, Drenos F, Cooper JA, Thompson
SR, Stephens JW, Hurt-Camejo E, Wiklund O, Humphries SE and Talmud
PJ: Tagging-SNP haplotype analysis of the secretory PLA2IIa gene
PLA2G2A shows strong association with serum levels of sPLA2IIa:
Results from the UDACS study. Hum Mol Genet. 15:355–361.
2006.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Simon T, Mallat Z, Kotti-Tounsi S,
Benessiano J, Lambeau G, Steg G, Allard-Latour G, Normand JP,
Bourlard P, Tedgui A, et al: Abstract 5908: Impact of Secretory
PLA2-IIa Gene Polymorphims on sPLA2 Activity and Cardiovascular
Events Following an AMI: Results From the French Registry of Acute
ST Elevation or Non-ST-elevation Myocardial Infarction (FAST-MI)
Registry. Circulation. 120 (Suppl 18)(S1174)2009.
|
|
42
|
Leinonen E, Hurt-Camejo E, Wiklund O,
Hultén LM, Hiukka A and Taskinen MR: Insulin resistance and
adiposity correlate with acute-phase reaction and soluble cell
adhesion molecules in type 2 diabetes. Atherosclerosis.
166:387–394. 2003.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Leinonen ES, Hiukka A, Hurt-Camejo E,
Wiklund O, Sarna SS, Mattson Hultén L, Westerbacka J, Salonen RM,
Salonen JT and Taskinen MR: Low-grade inflammation, endothelial
activation and carotid intima-media thickness in type 2 diabetes. J
Intern Med. 256:119–127. 2004.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Huggins KW, Boileau AC and Hui DY:
Protection against diet-induced obesity and obesity-related insulin
resistance in group 1B PLA2-deficient mice. Am J Physiol Endocrinol
Metab. 283:E994–E1001. 2002.PubMed/NCBI View Article : Google Scholar
|
